BrightAccountsProduction v1.0.0 v1.0.0 2025-01-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts FRS 105 Accounts The principal activity of the company is business and domestic software development. 16 April 2025 1 1 NI602978 2025-12-31 NI602978 2024-12-31 NI602978 2023-12-31 NI602978 2025-01-01 2025-12-31 NI602978 2024-01-01 2024-12-31 NI602978 uk-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 NI602978 uk-curr:PoundSterling 2025-01-01 2025-12-31 NI602978 uk-bus:AbridgedAccounts 2025-01-01 2025-12-31 NI602978 uk-core:CapitalReserve 2025-12-31 NI602978 uk-core:CapitalReserve 2024-12-31 NI602978 uk-core:ParentEntities 2025-01-01 2025-12-31 NI602978 2025-01-01 2025-12-31 NI602978 uk-bus:Director1 2025-01-01 2025-12-31 NI602978 uk-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 NI602978 uk-bus:Micro-entities 2025-01-01 2025-12-31 xbrli:pure iso4217:GBP xbrli:shares

Company Registration Number: NI602978

Protos Healthcare Limited

Unaudited Financial Statements

for the financial year ended 31 December 2025

Protos Healthcare Limited

Company Registration Number: NI602978

STATEMENT OF FINANCIAL POSITION

as at 31 December 2025

|  | 2025 |  | 2024
|  | £ |  | £
| Fixed Assets | - |  | 33,509
|  | ───────── |  | ─────────
| Current assets | 100 |  | 21,230
| Creditors: amounts falling due within one year | - |  | (40,764)
|  | ───────── |  | ─────────
| Net Current Assets/(Liabilities) | 100 |  | (19,534)
|  | ───────── |  | ─────────
| Total Assets less Current Liabilities | 100 |  | 13,975
| Accruals and deferred income | - |  | (1,750)
|  | ───────── |  | ─────────
| Net Assets | 100 |  | 12,225
|  | ═════════ |  | ═════════
| Capital and Reserves | 100 |  | 12,225
|  | ═════════ |  | ═════════
| Notes to the Financial statements

1. | General Information
| Protos Healthcare Limitedis a company limited by shares incorporated in Northern Ireland. The registered office of the company is 89-91 Academy Street, Belfast, BT1 2LS, which is also the principal place of business of the company. The financial statements have been presented in Pound (£) which is also the functional currency of the company.

2. | Employees
| The average monthly number of employees, including director, during the financial year was;
|  | 2025 | 2024
|  | Number | Number
| Directors | 1 | 1
|  | ═════════ | ═════════

3. | Parent company
| The company regards Cathedral Eye Holdings Ltd as its parent company.

4. | Controlling interest
| Cathedral Eye Holdings Ltd is considered the company's controlling interest as it holds 100% of the ordinary share capital of the company.

| For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
| The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
| The director acknowledges their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
| These financial statements have been prepared in accordance with the provisions available to micro-entities in Part 15 of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
| The company has taken advantage of the exemption under section 444 not to file the Director's Report, Income Statement.
| Approved by the Director on 16 April 2025 and signed by:
| ________________________________ |
| Prof. Jonathan Moore |
| Director |